Cat. #160853
VLS-VSCC cell line
Cat. #: 160853
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
Organism: Human
Disease: Cancer
Model: Cancer Model
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Daniela Elena Costea ; Harsh Dongre ; Line BjÄÂrge
Institute: Haukeland University Hospital; University of Bergen
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: VLS-VSCC cell line
- Alternate name: UB-VCC1
- Cancer: Gynaecologic cancer
- Cancers detailed: Vulvar lichen sclerosus and vulva squamous cell carcinoma
- Research fields: Cancer
- Organism: Human
- Disease: Cancer
- Growth properties: Doubling time: 18.90 ÄÂ? 0.53 hours
- Model: Cancer Model
- Conditional: No
- Description: A novel spontaneously immortalized cell line established from vulva squamous cell carcinoma associated with lichen sclerosus. Currently, there are no in vitro models to study VSCC-VLS. This is the first cell line modelling this disease.
- Production details: Spontaneously immortalized, i.e without any additional genetic alterations
- Cellosaurus id: CVCL_YD88
Applications
- Application notes: CVCL_YD88
Handling
- Format: Frozen
- Growth medium: Spontaneously immortalized, i.e without any additional genetic alterations DMEM/Nutrient Mixture F-12 Ham medium (D8437, Sigma) supplemented with 10% NBCS, 1X Insulin-Transferrin-Selenium (41400-04, Thermofisher Scientific), 0.4 ug/mL hydrocortisone (H0888, Sigma), 50ug/mL L-ascorbic acid (A7631, Sigma), and 10ng/mL epidermal growth factor (E9644, Sigma) Doubling time: 18.90 ÄÂ? 0.53 hours
- Unit size: 1x10^6 cells / vial
References
- Dongre et al. 2020. Exp Cell Res. 386(1):111684. PMID: 31654625.
